Sign up for news updates

Industry Connections

VIEW MORE

Industry Connections

VIEW MORE

Sponsored Content
This information is being distributed by the American Diabetes Association® (ADA) as a sponsor benefit. Reference to commercial products, processes, or services by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the ADA. The views and opinions of sponsors expressed herein do not necessarily state or reflect those of the ADA, and shall not be used for advertising or product endorsement purposes.

Learn more about Control-IQ+ technology and its recent approval for use with pregnancy.

Learn more at our Product Theater 

“Control‑IQ+ in Pregnancy: Results from the CIRCUIT RCT”
Saturday, June 6 | 10:15-11:00 a.m. CT | Product Theater 1

Speakers/Topic:

  • Denise Feig, University of Toronto – Study design and results
  • Ilana Halperin, University of Toronto – Patient case studies
  • Jordan Pinsker, Tandem Diabetes Care – Education and Training Resources

Visit Booth #901 

Tandem Diabetes Care will be at Booth #901. Visit us to learn more about the life-changing benefits of Control-IQ+ technology and demo our products. 

Attend our Poster Sessions 
Saturday, June 6 | 12:30-1:30 p.m. | Hall D-E

  • High User Satisfaction Continues Over Time with Tandem Mobile Apps and Control‑IQ+
  • PAUSE: Pump Absence Under Short Exposure Does Not Compromise Glycemia in Control-IQ+ Users
  • High Parental Satisfaction and Enhanced Quality of Life with Tandem Control-IQ+ in Very Young Children
Learn about Tandem AID